BioSpace News Archive

Drug Development

Phase III study shows quizartinib prolongs overall survival for patients with deadly type of relapsed or refractory AML

A study led by The University of Texas MD Anderson Cancer Center revealed that the investigational drug quizartinib prolonged overall survival for patients with a deadly form of acute myeloid leukemia (AML).

June 18, 2018
·
3 min read
Drug Development

Scientists Learn More about How Gene Linked to Autism Affects Brain

Study Suggests Modulating CHD8 Might Help Some People with Complex Condition

June 18, 2018
·
3 min read
Genetown

Cold Agglutinin Disease Associated with Greater Than Twofold Increased Risk of Mortality in First Five Years After Diagnosis

New study is first to identify an increased risk of death in people with cold agglutinin disease compared to the general population

June 18, 2018
·
4 min read
Biotech Bay

Twist Bioscience Expands Human Core Exome and Custom Next-Generation Sequencing Solutions with High Throughput Offering

Twist Human Core Exome Kit is a library preparation and target enrichment kit with the ability to run up to 96 samples simultaneously.

June 18, 2018
·
3 min read
Business

Dan Pelino Joins DNAmito’s Board Of Directors

Dan previously led IBM’s business in government, education, healthcare and life sciences.

June 18, 2018
·
1 min read
Pharm Country

IPsoft Launches Interactive AI Demonstration Lab, Amelia City, and Amelia Marketplace - the AI Industry’s First Off-the-Shelf AI Solutions for Banking, Insurance, Healthcare and More

Join IPsoft and Amelia, as they showcase her work in the banking, insurance, healthcare and many other industries in Amelia’s home - Amelia City

June 18, 2018
·
3 min read
Deals

MedMen Subordinate Voting Shares Approved for Inclusion on the OTC and Begin Trading on June 18th Under Ticker Symbol “MMNFF”

MedMen Enterprises Inc. is pleased to announce that the OTC Markets Group has approved the listing of the Company’s subordinate voting shares on its OTCQB Venture Market under the ticker symbol “MMNFF”.

June 18, 2018
·
2 min read
Galmed Pharmaceuticals Ltd. Announces Proposed Public Offering of Ordinary Shares

In addition, Galmed intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the ordinary shares sold in the offering, at the public offering price, less the underwriting discounts and commissions.

June 18, 2018
·
5 min read
Drug Development

BioLineRx Presents New Overall Survival Data From Phase 2a Study for BL-8040 in r/r AML Patients

Data presented at EHA shows significantly improved overall survival compared to historical data

June 18, 2018
·
6 min read
LG Chem Hosts Global Innovation Contest 2018 (GIC 2018) “Finding Innovations to Change the World”

LG Chem is exploring innovative technologies that will change the world.

June 18, 2018
·
2 min read